ABCD1 and adrenoleukodystrophy: Despite accumulation of VLCFAs (ACS and ABCD1 substrates) in ALD patients, it is still debated whether this marker of disease is also causative of disease, and whether accumulating VLCFAs should serve as a therapeutic target (Raymond et al., 1999).